We demonstrate that the Ad-mediated expression of shErbB3 could induce persistent silencing of ErbB3 and downregulation of its oncogenic signaling axis in in vitro models of breast cancer and that was well translated in in vivo tumor growth assays using a breast cancer xenograft model. Here, ERBB3 is linked to breast carcinoma.